Not applicableLooking for participantsNCT06949319
What this trial is testing
Stroke Risk Assessment and Markers of Blood Clotting in Patients With Newly Diagnosed Non-valvular Atrial Fibrillation (NVAF), Who Have Not Received Oral Anticoagulation Therapy (OAC-therapy) Prior to Inclusion
Who this might be right for
Atrial Fibrillation (AF)Atrial Fibrillation (Prevention of Stroke)Atrial Fibrillation New Onset+4 more
Nedim Tojaga 150